Related Experiment Video

Updated: May 18, 2026

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
09:13

Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases

Published on: November 22, 2024

TPCK inhibits AGC kinases by direct activation loop adduction at phenylalanine-directed cysteine residues

Rana Anjum1, Eunice Pae, John Blenis

  • 1Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.

FEBS Letters
|September 13, 2012
PubMed

Insights

N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) inhibits key cancer-related kinases like MSK1/2. TPCK targets conserved cysteine residues in AGC kinases, offering potential for new chemotherapy drugs.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) exhibits anti-tumorigenic effects.
  • The specific cellular targets of TPCK remain largely unknown.
  • Previous studies indicated TPCK inhibits PDK1-dependent AGC kinases (RSK, Akt, S6K1) but not PKA, ERK1/2, PI3K, or PDK1.

Purpose of the Study:

  • To identify the direct cellular targets of TPCK.
  • To elucidate the mechanism by which TPCK inhibits AGC kinases.
  • To explore the potential of TPCK and related compounds in cancer therapy.

Main Methods:

  • Mass spectrometry was employed to identify TPCK-modified proteins in treated cells.
  • Site-directed mutagenesis was used to analyze the role of specific cysteine residues.
  • Biochemical assays were performed to assess kinase inhibition.

Main Results:

  • TPCK was found to inhibit RSK-related kinases MSK1 and MSK2.
  • Mass spectrometry identified TPCK adducts on conserved cysteine residues within the activation loop (Phenylalanine-Cysteine motif) of RSK1, Akt1, S6K1, and MSK1.
  • Mutating these Phenylalanine-Cysteine residues resulted in partial resistance to TPCK inhibition.

Conclusions:

  • TPCK primarily inhibits AGC kinases by covalently modifying conserved cysteine residues in their activation loops.
  • This mechanism explains TPCK's broad inhibitory activity against multiple AGC kinases.
  • TPCK-like compounds show promise as chemotherapy agents due to their ability to broadly control cellular growth, proliferation, and survival pathways.

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...